[ad_1] Teva's lobbying expenses of $ 1.6 million in the first half of 2018 are down 54% from the same period in 2017. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported to the …
Read More »Teva lobbying spending in the United States reaches $ 1.1 billion in the first quarter
